SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056507
Filing Date
2021-11-12
Accepted
2021-11-12 08:26:14
Documents
14
Period of Report
2021-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q3'21 8-K alxo-8k_20211111.htm   iXBRL 8-K 41312
2 EX-99.1 alxo-ex991_6.htm EX-99.1 249948
3 GRAPHIC golhi5w2greh000001.jpg GRAPHIC 27266
  Complete submission text file 0001564590-21-056507.txt   474564

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alxo-20211111.xsd EX-101.SCH 5697
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20211111_lab.xml EX-101.LAB 19323
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20211111_pre.xml EX-101.PRE 11492
7 EXTRACTED XBRL INSTANCE DOCUMENT alxo-8k_20211111_htm.xml XML 3556
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 211399896
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences